Skip to main content
Clinical Trials/NCT03367247
NCT03367247
Completed
N/A

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

Dana-Farber Cancer Institute1 site in 1 country121 target enrollmentApril 24, 2018

Overview

Phase
N/A
Intervention
BOLSTER
Conditions
Gynecologic Cancer
Sponsor
Dana-Farber Cancer Institute
Enrollment
121
Locations
1
Primary Endpoint
Feasibility of the BOLSTER Intervention
Status
Completed
Last Updated
last month

Overview

Brief Summary

This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.

Detailed Description

Hospitalizations can be difficult for patients with cancer, especially when they are transitioning home. Patients and caregivers are often expected to perform complex medical and nursing tasks with little or no preparation. Patients and caregivers report high levels of unmet needs for information about how best to manage symptoms and new medical procedures (such as managing new tubes, lines or drains). The study team has developed a research project which aims to address these needs. If a patient agrees to participate in the study, she will take part in a program called BOLSTER (Building Out Lifelines for Safety, Trust, Empowerment and Renewal). BOLSTER will provide patients and caregivers with education and skills training, symptom management, and support across care settings.

Registry
clinicaltrials.gov
Start Date
April 24, 2018
End Date
July 27, 2023
Last Updated
last month
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Alexi A. Wright, MD

Principal Investigator

Dana-Farber Cancer Institute

Eligibility Criteria

Inclusion Criteria

  • Patient inclusion criteria
  • Adults (≥18 years old);
  • GYN or GI cancers receiving anti-neoplastic therapy;
  • Hospitalized, recently hospitalized (i.e. within the first 2 visits after a hospitalization), or recent outpatient placement of tube, line, or drain (e.g. PleurX catheter);
  • Plan to receive ongoing care at DFCI;
  • Willingness to be audio taped for the study (for monitoring of study fidelity).
  • Have complex care needs (e.g. an ostomy, ileostomy, a gastric tube, percutaneous nephrostomy tubes, a PleurX catheter, or need for total parenteral nutrition)

Exclusion Criteria

  • Unable to read and respond to questions in English;
  • Cognitive impairment;
  • Unable to complete the baseline interview;
  • Plan for immediate hospice referral
  • Caregiver inclusion criteria
  • Adults (≥18 years old);
  • Family member or friend of an eligible patient;
  • Willingness to be audio taped for the study (for monitoring of study fidelity);
  • Willingness to participate in study visits
  • Caregiver exclusion criteria:

Arms & Interventions

Bolster

* Bolster provides participants with longitudinal nursing support across care settings, * A smartphone-based symptom management app, * A print and web-based symptom management toolkit, * Advance care planning to ensure that the patient receives care that is congruent with her informed preferences * BOLSTER includes a total of 6 contacts with a study nurse over 4 weeks * Daily contact via a smartphone-based symptom app which queries patients about their symptoms using questions from the PRO-CTCAE, risk-stratifies their symptoms, and provides tailored symptom management advice

Intervention: BOLSTER

Enhanced Discharge Planning (EDP)

* Medication education, * Self-management strategies for symptoms, * Skills training, * A list of red flag symptoms and numbers for who to call

Intervention: Enhanced Discharge Planning (EDP)

Outcomes

Primary Outcomes

Feasibility of the BOLSTER Intervention

Time Frame: 1 month

≥50% consent-to-approach ratio

Secondary Outcomes

  • Acceptability of the BOLSTER Intervention(3 months)

Study Sites (1)

Loading locations...

Similar Trials